SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55: 244-265.
  • 2
    Paavonen J, Lehtinen M. Introducing human papillomavirus vaccines - questions remain. Ann Med. 2008; 40: 162-166.
  • 3
    American Cancer Society. How many women get cancer of the cervix? http://www.cancer.org/Cancer/CervicalCancer/OverviewGuide/cervical-cancer-overview-key-statistics. Accessed June 28, 2011.
  • 4
    Healthy People 2020. Sexually transmitted diseases. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?top icId=37 Accessed June 23, 2011.
  • 5
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56( RR-2): 1-24.
  • 6
    McDougall JA, Madeleine MM, Daling JR, Li CI. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 2007; 18: 1175-1186.
  • 7
    Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003; 105: 687-691.
  • 8
    Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004; 101: 1051-1057.
  • 9
    O'Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health. 2006; 96: 2179-2185.
  • 10
    Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13 through 17 years — United States, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1117-1123.
  • 11
    Staras SA, Vadaparampil ST, Haderxhanaj LT, Shenkman EA. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008. J Adolesc Health. 2010; 47: 381-388.
  • 12
    Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine. 2011; 29: 528-534.
  • 13
    Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010; 47: 596-599.
  • 14
    Biro FM, Rosenthal SL, Rymarquis L, Kollar LM, Hillard PJ. Adolescent girls' understanding of Papanicolaou smear results. J Pediatr Adolesc Gynecol. 1997; 10: 209-212.
  • 15
    Burak LJ, Meyer M. Using the Health Belief Model to examine and predict college women's cervical cancer screening beliefs and behavior. Health Care Women Int. 1997; 18: 251-262.
  • 16
    Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res. 2002; 17: 706-714.
  • 17
    Mays RM, Zimet GD, Winston Y, Kee R, Dickes J, Su L. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int. 2000; 21: 361-374.
  • 18
    Horn JE, McQuillan GM, Ray PA, Hook EW 3rd. Reproductive health practices in women attending an inner-city STD clinic. Sex Transm Dis. 1990; 17: 133-137.
  • 19
    Jubelirer SJ, Blanton MF, Blanton PD, et al. Assessment of knowledge, attitudes, and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996; 11: 230-232.
  • 20
    Nugent LS, Tamlyn-Leaman K. The colposcopy experience: what do women know? J Adv Nurs. 1992; 17: 514-520.
  • 21
    Ramirez JE, Ramos DM, Clayton L, Kanowitz S, Moscicki AB. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health. 1997; 6: 113-121.
  • 22
    Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009; 18: 363-372.
  • 23
    Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009; 45: 453-462.
  • 24
    Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2011; 29: 890-895.
  • 25
    Guerry SL, De Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011; 29: 2235-2241.
  • 26
    Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009; 45: 430-437.
  • 27
    Vadaparampil ST, Kahn JA, Salmon D, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine. 2011; 29: 8634-8641.
  • 28
    Dillman D. Mail and Internet Surveys: The Tailored Design Method. New York, NY: Wiley; 2000.
  • 29
    Lindley MC, Smith PJ, Rodewald LE. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Rep. 2011; 126: 124-134.
  • 30
    Bartlett JA, Peterson JA. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs. 2011; 27: 434-446.
  • 31
    Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010; 171: 357-367.
  • 32
    Szilagyi PG, Rodewald LE, Humiston SG, et al. Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics. 1993; 91: 1-7.
  • 33
    Fiks AG, Hunter KF, Localio AR, Grundmeier RW, Alessandrini EA. Impact of immunization at sick visits on well-child care. Pediatrics. 2008; 121: 898-905.
  • 34
    Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007; 161: 252-259.
  • 35
    Oster NV, McPhillips-Tangum CA, Averhoff F, Howell K. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005; 18: 13-19.
  • 36
    Centers for Disease Control and Prevention. Vaccines for Children Program (VFC). http://www.cdc.gov/vaccines/programs/vfc/default. htm. Accessed November 4, 2011.
  • 37
    National Cancer Institute. NCI Fact Sheet: Cancer Health Disparities. http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health-disparities. Accessed January 6, 2012.
  • 38
    US Food and Drug Administration. FDA approves new indication for Gardasil to prevent genital warts in men and boys. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187003.htm. Accessed August 17, 2011.
  • 39
    Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010; 47: 3-11.
  • 40
    Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60: 1705-1708.